#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chorioretinitis Turner's syndrome Idiopathic inflammatory myopathy Immunodeficiency common variable Nephroblastoma Epstein-Barr virus associated lymphoproliferative disorder Small cell lung cancer Marginal zone lymphoma recurrent Shprintzen-Goldberg syndrome Becker's muscular dystrophy Choroidal dystrophy Antithrombin III deficiency Extranodal marginal zone B-cell lymphoma (MALT type) Intracranial calcification Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Trials in Disease Prolymphocytic leukaemia – Treatment Idiopathic pulmonary fibrosis Haemophilia Glycogen storage disease type II – Treatment Alveolar rhabdomyosarcoma – Trials in Disease Tuberous sclerosis complex – Treatment Combined immunodeficiency – Diagnostics Medulloblastoma Lymphatic malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phosphocreatine Sodium Varenicline Daxdilimab Fluorouracil Sodium Itolizumab Rosuvastatin Fluticasone Furoate ORX750 Procarbazine Hydrochloride Cabozantinib Elraglusib Methionine Peposertib Potato Starch L-Threonine Nesolicaftor Dl-Alpha Tocopherol Acetate TETRODOTOXIN Acetylcysteine INDAPAMIDE HEMIHYDRATE More therapies…

    Learn about Your Condition

    Optic glioma Pterygium Nervous system disorder Head and neck cancer stage III Retroperitoneal cancer Perthes disease Meningioma malignant Peritoneal sarcoma Perineal injury Lupus nephritis Proteinuria Hypersomnia Chordoma Complex regional pain syndrome Retinoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Lurbinectedin
    • Topotecan
    • Irinotecan
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Anaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Germany Italy Poland Spain

  • Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Alpelisib
    • Fulvestrant
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    Belgium France Hungary Ireland Italy Spain

  • Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Chlorambucil
    • Acalabrutinib
    • Obinutuzumab
    Belgium France Germany Hungary Italy Lithuania +3

  • Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Sorafenib
    • Durvalumab
    • Infliximab
    France Germany Italy Spain

  • Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tirbanibulin
    • Diclofenac Sodium
    France Germany Italy Poland Spain

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4

  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vorasidenib
    France Germany Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Italy Poland Spain
Previous Page
1 … 56 57 58 59 60 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!